Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2000-04-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.97.9.4897PMID 10781096PMCID PMC18329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

  2000cited by this paper
• Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein

  1999cited by this paper
• No pathogenic mutations in the β-synuclein gene in Parkinson's disease

  1999cited by this paper
• alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.

  1999cited by this paper
• Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

  1999cited by this paper
• No pathogenic mutations in the beta-synuclein gene in Parkinson's disease.

  1999cited by this paper
• Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease.

  1999cited by this paper
• No pathogenic mutations in the persyn gene in Parkinson's disease.

  1999cited by this paper
• Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation*

  1999cited by this paper
• Glutamine repeats and neurodegenerative diseases: molecular aspects.

  1999cited by this paper
• Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein.

  1999cited by this paper
• Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro *

  1999cited by this paper
• Yeast prion [psi +] and its determinant, Sup35p.

  1999cited by this paper
• Degradation of α-Synuclein by Proteasome*

  1999cited by this paper
• α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein Components

  1999cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• Filamentous nerve cell inclusions in neurodegenerative diseases.

  1998cited by this paper
• Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System

  1998cited by this paper
• Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

  1998cited by this paper
• Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• From the globular to the fibrous state: protein structure and structural conversion in amyloid formation

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

  1998cited by this paper
• Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?

  1998cited by this paper
• α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

  1998cited by this paper
• Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

  1998cited by this paper
• Synthetic filaments assembled from C‐terminally truncated α‐synuclein

  1998cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

  1997cited by this paper
• Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

  1996cited by this paper
• Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.

  1996cited by this paper
• Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix

  1996cited by this paper
• Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

  1995cited by this paper
• Identification of two distinct synucleins from human brain

  1994cited by this paper
• Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

  1994cited by this paper
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

  1993cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament.

  1993cited by this paper
• Cloning and Characterization of the cDNA Encoding a Novel Brain‐Specific 14‐kDa Protein

  1992cited by this paper
• Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

  1992cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• The rat brain synucleins; family of proteins transiently associated with neuronal membrane.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• Straight and paired helical filaments in Alzheimer disease have a common structural unit.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• Lewy bodies in cerebral cortex. Report of three cases

  1978cited by this paper
• X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS

  1968cited by this paper
• “Cross-β” conformation in proteins☆

  1968cited by this paper
• "Cross-beta" conformation in proteins.

  1968cited by this paper
• Cholinesterase localization in the dorsal root ganglion of the rabbit embryo by electron microscopic histochemistry.

  1967cited by this paper
• Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease

  1965cited by this paper
• CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASES

  1962cited by this paper
• DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION

  1961cited by this paper
• Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

  1959cited by this paper
• Paralysis agitans. I. Pathologische Anatomie

  year unknowncited by this paper

• Detection and Profiling of Neurodegenerative Disease-Related Extracellular Vesicles through Membrane and Cargo Proteins.

  2026cites this paper
• Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease.

  2026cites this paper
• Tandem FAIMS and IMS Combined with MS/MS for Effectively Probing the Structural Diversity of Proteins.

  2026cites this paper
• Type‐Specific Single‐Neuron Analysis Reveals Mitochondrial DNA Maintenance Failure Affecting Atrophying Pontine Neurons Differentially in Lewy Body Dementia Syndromes

  2025cites this paper
• Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates

  2025cites this paper
• Distinct alpha-synuclein strains derived from Parkinson’s disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model

  2025cites this paper
• Protein Recognition of Linear and Cyclic Peptides of Homologous Sequences Implicated in the Aggregation of α‑Synuclein

  2025cites this paper
• High-resolution Cryo-EM Structure Determination of a-Synuclein—A Prototypical Amyloid Fibril

  2025cites this paper
• Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration

  2025cites this paper
• Inhibition of α-synuclein aggregation by hesperidin as a potent anti-amyloidogenic polyphenol: A computational approach and MM-PBSA /ADMET analysis

  2025cites this paper
• Effect of RNA on the supramolecular architecture of α-synuclein fibrils

  2025cites this paper
• Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity.

  2025cites this paper
• Amyloid formation of alternatively spliced variants of α‐synuclein

  2025cites this paper
• Nuclear Medicine Imaging Biomarkers in Parkinson’s Disease: Past, Present, and Future Directions

  2025cites this paper
• Using a stable protein scaffold to display peptides that bind to alpha‐synuclein fibrils

  2025cites this paper
• Guide to the structural characterization of protein aggregates and amyloid fibrils by CD spectroscopy

  2025cites this paper
• Adenine bolsters the monomeric conformations of the intrinsically disordered A53T mutant of α-Synuclein protein

  2025cites this paper
• Alpha-Synuclein Neurobiology in Parkinson’s Disease: A Comprehensive Review of Its Role, Mechanisms, and Therapeutic Perspectives

  2025cites this paper
• Cholesterol modulates vesicle clustering mediated by alpha-synuclein in a nonlinear fashion

  2025cites this paper
• Plant-based protein nanofibers: A comprehensive review of fabrication techniques, structural properties, and bifunctional applications.

  2025cites this paper
• Cardiolipin-Based Nanoparticles Inhibit α-Synuclein Fibrilization.

  2025cites this paper
• The mechanisms underlying TDP-43-associated neurodegeneration in Alzheimer’s disease and related dementias

  2025cites this paper
• Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook.

  2025cites this paper
• “Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders

  2024cites this paper
• Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases

  2024cites this paper
• Synthetic β-sheets mimicking fibrillar and oligomeric structures for evaluation of spectral X-ray scattering technique for biomarker quantification

  2024influential citation
• Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach

  2024cites this paper
• High-Resolution Cryo-EM Structure Determination of α-synuclein – A Prototypical Amyloid Fibril

  2024cites this paper
• The Structural Features of Skeletal Muscle Titin Aggregates

  2024influential citation
• VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates

  2024cites this paper
• Current insights and assumptions on α-synuclein in Lewy body disease

  2024cites this paper
• The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease

  2024cites this paper
• Structural features of skeletal muscle titin aggregates

  2024cites this paper
• Multi-Site Red-Edge Excitation Shift Reveals the Residue-Specific Solvation Dynamics during the Native to Amyloid-like Transition of an Amyloidogenic Protein.

  2024cites this paper
• Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation

  2024cites this paper
• Nanofibrous Peptide Hydrogels Leveraging Histidine to Modulate pH-Responsive Supramolecular Assembly and Antibody Release.

  2024cites this paper
• Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

  2024cites this paper
• Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice

  2024cites this paper
• RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation.

  2024cites this paper
• The small molecule ZPD‐2 inhibits the aggregation and seeded polymerisation of C‐terminally truncated α‐Synuclein

  2024cites this paper
• Computer aided therapeutic tripeptide design, in alleviating the pathogenic proclivities of nocuous α-synuclein fibrils

  2023cites this paper
• Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering

  2023cites this paper
• Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models

  2023cites this paper
• Truncation or proteolysis of α-synuclein in Parkinsonism.

  2023cites this paper
• Ultrastiff Amyloid-Fibril Network of α-Synuclein Formed by Surface Seeding Reaction Confirmed by Multichannel Electrodeless Quartz-Crystal-Microbalance Biosensor.

  2023cites this paper
• Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases

  2023cites this paper
• Hydrogen-Deuterium Exchange Vibrational Raman Spectroscopy Distinguishes Distinct Amyloid Polymorphs Comprising Altered Core Architecture.

  2023cites this paper
• Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia

  2023cites this paper
• Amyloid fibril formation, structure and domain swapping of acyl‐coenzyme A thioesterase‐7

  2023cites this paper
• Lipid‐induced polymorphic amyloid fibril formation by α‐synuclein

  2023cites this paper
• Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia

  2023cites this paper
• Taking Charge: Metal Ions Accelerate Amyloid Aggregation in Sequence Variants of α-Synuclein

  2023cites this paper
• α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies

  2023cites this paper
• The biology, pathological roles of exosomes and their clinical application in Parkinson's disease.

  2023cites this paper
• Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine

  2023cites this paper
• The Anthocyanidin Peonidin Interferes with an Early Step in the Fibrillation Pathway of α-Synuclein and Modulates It toward Amorphous Aggregates.

  2023cites this paper
• Sensitized Emission Imaging Allows Nanoscale Surface Polarity Mapping of α-Synuclein Amyloid Fibrils.

  2023cites this paper
• Monitoring α-synuclein aggregation

  2023cites this paper
• Influence of Protonation on the Norepinephrine Inhibiting α-Synuclein 71-82 Oligomerization.

  2023cites this paper
• Comparing α-Synuclein Fibrils Formed in the Absence and Presence of a Model Lipid Membrane: A Small and Wide-Angle X-Ray Scattering Study

  2022influential citation
• Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants

  2022cites this paper
• Ingenuity pathway analysis of α-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases

  2022cites this paper
• Phase separation and other forms of α-Synuclein self-assemblies.

  2022cites this paper
• Functional interaction between α-synuclein and Nurr1 in dopaminergic neurons.

  2022cites this paper
• Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies

  2022cites this paper
• Clinical Presentation, Diagnosis, and Pathogenesis of Dementia With Lewy Bodies

  2022cites this paper
• Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic.

  2022cites this paper
• Change in the Oligomeric State of α-Synuclein Variants in Living Cells.

  2022cites this paper
• Second Sphere Interactions in Amyloidogenic Diseases.

  2022cites this paper
• α-Synuclein A53T Promotes Mitochondrial Proton Gradient Dissipation and Depletion of the Organelle Respiratory Reserve in a Neuroblastoma Cell Line

  2022cites this paper
• Neuropathology of α‐synuclein in Parkinson's disease

  2022cites this paper
• Neuronal cell death mechanisms in Alzheimer’s disease: An insight

  2022cites this paper
• Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective

  2022cites this paper
• Structures of α-synuclein filaments from human brains with Lewy pathology

  2022cites this paper
• The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains

  2022cites this paper
• Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s disease

  2022influential citation
• Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson’s Disease

  2022cites this paper
• Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation.

  2022cites this paper
• Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold

  2022cites this paper
• Neurons with Cat’s Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions

  2022cites this paper
• α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

  2022cites this paper
• Structural and Functional Insights into α-Synuclein Fibril Polymorphism

  2021cites this paper
• Target-binding behavior of IDPs via pre-structured motifs.

  2021cites this paper
• On the Cluster Formation of α-Synuclein Fibrils

  2021cites this paper
• Insights into neurodegeneration from electron microscopy studies

  2021cites this paper
• Alpha-Synuclein Aggregation in Parkinson's Disease

  2021cites this paper
• Myosin Binding Protein-C Forms Amyloid-Like Aggregates In Vitro

  2021cites this paper
• Animal models of brain-first and body-first Parkinson's disease.

  2021cites this paper
• The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders

  2021cites this paper
• Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease

  2021cites this paper
• Tryptophan‐cardanol fluorescent nanoparticles inhibit α‐synuclein aggregation and disrupt amyloid fibrils

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• Investigation of Inhibition Effect of Nicotine and Dopamine on Alpha-synuclein

  2021cites this paper
• Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions.

  2021cites this paper
• Neuronal hemoglobin induces α-synuclein cleavage and loss of dopaminergic neurons

  2021cites this paper
• Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of α-synuclein fibrillation: Biophysical and insilico studies

  2021cites this paper
• Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons

  2021cites this paper
• In vivo visualization of propagating α -synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05

  2021cites this paper
• α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques

  2021cites this paper
• Neuronal autophagy and mitophagy in Parkinson's disease.

  2021cites this paper